Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Embera's phase I study of EMB-001 to receive funding from Sounds Affects Life

July 4, 2014

Japanese researchers present radiation-induced injury treatments

June 27, 2014

Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy

June 25, 2014

Bunavail buccal film approved by FDA for opioid dependence

June 11, 2014

Pfizer researchers design nicotine vaccines with higher avidity

May 26, 2014

Double-blind trial finds (S)-(-)-OSU-6162 effective in treating alcohol dependence

May 9, 2014

FDA approves Evzio for the emergency treatment of opioid overdose

April 7, 2014

Medesis Pharma and CEA sign collaborative agreement

April 3, 2014

Southwest Research Institute receives contract extension for cyanide antidote

March 31, 2014

New monoclonal antibodies for the treatment of botulism disclosed

March 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.